3,615 MWh per year of power generation capacity in photovoltaic plants, installed in nine schools
17% of the total energy consumed by operations is supplied by solar energy, versus 8% in 2021
-63% of scope 2 emissions (emissions from electric energy consumption)
5,440+ people impacted by our initiatives concerning education and environmental awareness, promoted by the schools
7,960+ people benefited from the social responsibility initiatives carried out by our operations
3 tons of food collected in campaigns carried out by IPEMEDs and distributed to local communities
57% of employees are women
41% of management positions are held by women
40% of the members of the Board of Directors are women
30% of the members of the Board are independent
89% of the employees attended training programs on Fighting Corruption and Fraud
471,107 free healthcare consultations to the communities surrounding the campuses
18,104 physicians graduated until 2022
14,000+ people impacted by healthcare promotion and disease prevention initiatives carried out by the schools
In 2022, we proceeded with the strategy of consolidating our leadership in Medical Education. We acquired Unit Alagoas (AL) and Fits Jaboatão dos Guararapes (PE), and inaugurated four Medicine education units inserted in the Mais Médicos program: two of them, in Pará, and two in Amazonas, further strengthening our operations in the Northern Region of the country.
32 schools, in 14 states
30 schools offering Medicine course
63% of our schools in operation are located outside major cities, reinforcing our proposal to interiorize medical education
69% of the schools are located in the North and Northeast regions
50% of the faculty members are Master's and/or PhDs
> A map with all our schools can be viewed here.
In this business vertical, we operate through IPEMED, driven by a strategy that is based on increasing the geographic reach and the offer of courses:
Physical presence in 13 Brazilian cities, a number that includes two inaugurations during the year: in Montes Claros (MG) and Porto Velho (RO)
56 active courses – 34 launched in 2022 –, including in-person, hybrid, and distance learning
215 active classes
18 medical specialties and multidisciplinary courses
1,068 registered professors
166 institutional partnerships
> A map showing the IPEMED units can be viewed here.
Our ecosystem brings together 11 healthtechs, which enable us to support physicians in the performance of their professional activities, by offering everything from the decision-making support at the bedside, patient relations and management of clinics and practices, for example, to content and continued learning. All these solutions are gathered in the group we call B2P (business to physician):
1. Content & Technology for Medical Education (Medcel, Além da Medicina, Medical Harbour and CardioPapers)
2. Clinical Decision Suport (Whitebook and Pebmed)
3. Practice Management Tools & Electronic Medical Record (iClinic, Shosp, RX PRO and AgendarConsulta.com)
4. Telemedicine (iClinic)
5. Digital Prescription (iClinic Rx)
6. Physician-Patient Relationship (Glic and CliqueFarma)
> Download infographic.
At the close of 2022, B2P digital solutions comprised more than 260,000 active users*, including physicians and medical students:
16,539 in Content & Technology for Medical Education
221,762 in Clinical Decision Support and Medical Update
20,936 in Electronic Records and Office Management
1,473 in Physician-Patient Relationship
* A physician or student can be user of more than one solution
We also provide the connection between the physicians who use our ecosystem and the various segments of the health area, such as pharmaceutical manufacturers, laboratories, drugstore chains and hospitals, as well as health insurance operators and health insurers. This front - called B2B (business to business) was created in 2022, and initially focused on the pharmaceutical industry. During the period, it captured:
97 contracts
45 clients, which includes names such as Pfizer, Bayer, GSK, Roche, Boehringer Ingelheim, Abbott, Janssen, and Eurofarma
in Adjusted Net Revenue
in Adjusted Net Income
in Adjusted EBITDA
in Adjusted Operating Cash Flow
Adjusted EBITDA Margin
Cash Conversion